Muscle Vibration as a Countermeasure Against Hypoactivity-induced
NCT ID: NCT07021079
Last Updated: 2025-11-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
42 participants
INTERVENTIONAL
2025-06-16
2027-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing of a New Therapeutic Vibration Device to Reduce Neuromuscular Weakness in Hospitalized Patients
NCT03479008
Less is Better? Effectiveness of a Short Local Vibration Protocol on Neuromuscular Function
NCT07344298
Impact of Whole Body Vibration on Muscle Function and Respiratory Parameters in Intensive Care Patients
NCT06872697
Effects of Neuromuscular Electrical Stimulation on Critically Ill Patients With Mechanical Ventilation
NCT05217511
Bed Rest and Muscle Strength in ICU: Interest in the Early Association of NEMS With Cyclo-ergometer Mobilization
NCT03987997
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VIBRATION
Participants will benefit a local vibration countermeasure program for the knee extensor muscles.
Focal muscle vibration
focal muscle vibration sessions, using small and portable vibrator devices.
CONTROLE
the control group WILL not receive this countermeasure.
NO Focal muscle vibration
The control group will not receive any intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Focal muscle vibration
focal muscle vibration sessions, using small and portable vibrator devices.
NO Focal muscle vibration
The control group will not receive any intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18 to 45 years.
* Body Mass Index (BMI) between 20 and 25 kg/m².
* Engaging in at least 1.5 hours per week of physical activity (e.g., brisk walking, running, swimming, cycling).
* Provided informed consent after receiving detailed information about the study.
* Affiliated with or beneficiaries of a social security system
Exclusion Criteria
* Personal history and/or risk factors for thrombosis.
* Use of antidepressant medications.
* Use of neuroactive substances likely to alter corticospinal excitability (e.g., hypnotics, antiepileptics, psychotropics, muscle relaxants) during the study.
* Recent bone or ligament trauma within the past 12 months.
* Inability to perform the physical efforts required for the study.
* Recent participation in a sporting competition or intense, unusual physical activity within the past month.
* Corticosteroid treatment within the past 3 months.
* Any skin lesions at the planned vibrator application site.
* Simultaneous participation in another interventional medical study.
* Pregnant or breastfeeding women.
* Individuals unable to understand the purpose and conditions of the study or unable to provide informed consent.
* Individuals deprived of liberty or under guardianship
19 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LEONARD FEASSON, PHD
Role: PRINCIPAL_INVESTIGATOR
CENTRE HOSPITALIER UNIVERSITAIRE SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-A02769-38
Identifier Type: OTHER
Identifier Source: secondary_id
24CH295
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.